Stay updated on Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial
Sign up to get notified when there's something new on the Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial page.

Latest updates to the Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding-lapse notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check21 days agoChange DetectedNotice about a lapse in government funding and that the NIH Clinical Center is open, along with the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedMinor UI and data formatting updates: the Czech location is shown as 'Brno-Bohunice, Czechia, 625 00' instead of 'Brno Bohunice, Czechia, 625 00', a glossary display option was added, capitalization tweaks to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and the revision tag updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing v3.3.3; this appears to be a minor technical update that does not affect study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations sections were expanded to include US states, Canadian provinces, and European regions, accompanied by a new revision tag v3.3.3. The prior location blocks associated with v3.3.2 were removed/adjusted to reflect the update.SummaryDifference2%

- Check92 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page, which is a minor version change and does not affect study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Mylan Insulin Glargine with Lantus in T1DM Clinical Trial page.